Gestofit 300mg SR Tablet contains natural micronized progesterone, a bioidentical hormone essential for regulating the menstrual cycle and maintaining pregnancy. This sustained-release formulation ensures a gradual and consistent release of progesterone, optimizing therapeutic efficacy and minimizing fluctuations in hormone levels. Progesterone plays a critical role in preparing the endometrium for embryo implantation and supporting early pregnancy by maintaining the uterine lining. Gestofit is commonly prescribed for conditions such as luteal phase deficiency, secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance, and as part of hormone replacement therapy in menopausal women. It is also utilized in assisted reproductive technologies to support the luteal phase following ovulation induction or embryo transfer. The natural micronized form enhances gastrointestinal absorption and bioavailability compared to synthetic analogs. Administration should be as directed by a healthcare professional, with dosage tailored to the specific clinical indication. Potential side effects may include dizziness, headache, breast tenderness, and mild gastrointestinal disturbances. Contraindications include known hypersensitivity to progesterone, active thrombophlebitis, or hormone-dependent malignancies. Regular monitoring is advised to assess therapeutic response and detect any adverse effects. Gestofit 300mg SR Tablet offers a reliable and physiologically compatible option for progesterone supplementation in various gynecological and reproductive health conditions.